Ulcerative Colitis
Ulcerative colitis (UC) is a chronic condition that causes inflammation and ulcers in the lining of the colon, leading to symptoms such as abdominal pain, diarrhea, and rectal bleeding.
Ulcerative Colitis: RO7790121 Treatment Study
We are studying a new treatment for people with moderately to severely active ulcerative colitis to see if it can help induce remission. The trial will also assess its safety and impact on symptoms and quality of life.
Confirmation phase (III)Post-Trial Drug AccessCost ReimbursementPartially RemoteGastroenterologyInternal Medicine
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 80 years old?
- Do you have a confirmed diagnosis of ulcerative colitis (UC)?
- Do you have moderately to severely active ulcerative colitis?
- Have you had any major surgery in the past 6 weeks?
- Do you have a current diagnosis of Crohn's disease or any other major bowel condition?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Ordensklinikum Linz GmbH
Department of internal medicine IV
Linz, Austria
Klinikum Wels-Grieskirchen GmbH
Department of Internal Medicine I
Wels, Austria
Onze-Lieve-Vrouwziekenhuis
Gastro-enterology
Aalst, Belgium
Sponsor: F. Hoffmann-La Roche AG
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.